Boehringer Ingelheim Investigational Site
Tucson, Arizona 85712
0 studies enrolling now · 4 studies all time
What they study most
Diabetes Mellitus, Type 2, Hypertension, Parkinson Disease
Studies at this site
- PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN — Completed
- SMOOTH - Blood Pressure Control in Diabetic/Obese Patients — Completed
- A Randomized, Double-blind, Placebo Controlled Comparison of Telmisartan Hydrochlorothiazide (HCT) and Valsartan HCT in Hypertension (HTN) Stage I/II Patients — Completed
- A Fourteen-Week Placebo-Controlled Dose-Response Efficacy and Safety Study of NS 2330 in Early Parkinson's Disease Patients (Study for Proof of Concept in Early Parkinson's Disease of a Triple Reuptake Inhibitor, NS 2330 / SCEPTRE) — Completed